233 related articles for article (PubMed ID: 20352156)
21. Microvesicle release is associated with extensive protein tyrosine dephosphorylation in platelets stimulated by A23187 or a mixture of thrombin and collagen.
Pasquet JM; Dachary-Prigent J; Nurden AT
Biochem J; 1998 Aug; 333 ( Pt 3)(Pt 3):591-9. PubMed ID: 9677317
[TBL] [Abstract][Full Text] [Related]
22. Evidence that agonist-induced activation of calpain causes the shedding of procoagulant-containing microvesicles from the membrane of aggregating platelets.
Fox JE; Austin CD; Reynolds CC; Steffen PK
J Biol Chem; 1991 Jul; 266(20):13289-95. PubMed ID: 2071604
[TBL] [Abstract][Full Text] [Related]
23. Maintaining flippase activity in procoagulant platelets is a novel approach to reducing thrombin generation.
Millington-Burgess SL; Harper MT
J Thromb Haemost; 2022 Apr; 20(4):989-995. PubMed ID: 35034417
[TBL] [Abstract][Full Text] [Related]
24. Concurrent and separate inside-out transition of platelet apoptosis and activation markers to the platelet surface.
Mutlu A; Gyulkhandanyan AV; Freedman J; Leytin V
Br J Haematol; 2013 Nov; 163(3):377-84. PubMed ID: 24033315
[TBL] [Abstract][Full Text] [Related]
25. Phosphatidylserine surface expression and integrin alpha IIb beta 3 activity on thrombin/convulxin stimulated platelets/particles of different sizes.
Rukoyatkina N; Begonja AJ; Geiger J; Eigenthaler M; Walter U; Gambaryan S
Br J Haematol; 2009 Feb; 144(4):591-602. PubMed ID: 19036116
[TBL] [Abstract][Full Text] [Related]
26. Calpeptin, not calpain, directly inhibits an ion channel of the inner mitochondrial membrane.
Derksen M; Vorwerk C; Siemen D
Protoplasma; 2016 May; 253(3):835-843. PubMed ID: 26108743
[TBL] [Abstract][Full Text] [Related]
27. Intact platelet membranes, not platelet-released microvesicles, support the procoagulant activity of adherent platelets.
Swords NA; Tracy PB; Mann KG
Arterioscler Thromb; 1993 Nov; 13(11):1613-22. PubMed ID: 8218102
[TBL] [Abstract][Full Text] [Related]
28. Merocyanine 540 as a fluorescent probe of altered membrane phospholipid asymmetry in activated whole blood platelets.
Watala C; Waczulikova I; Wieclawska B; Rozalski M; Gresner P; Gwoździński K; Mateasik A; Sikurova L
Cytometry; 2002 Nov; 49(3):119-33. PubMed ID: 12442312
[TBL] [Abstract][Full Text] [Related]
29. Characteristics of various synthetic peptide calpain inhibitors and their application for the analysis of platelet reaction.
Ariyoshi H; Shiba E; Kambayashi J; Sakon M; Tsujinaka T; Uemura Y; Mori T
Biochem Int; 1991 Apr; 23(6):1019-33. PubMed ID: 1953797
[TBL] [Abstract][Full Text] [Related]
30. Apoptotic-like mitochondrial events associated to phosphatidylserine exposure in blood platelets induced by local anaesthetics.
Augereau O; Rossignol R; DeGiorgi F; Mazat JP; Letellier T; Dachary-Prigent J
Thromb Haemost; 2004 Jul; 92(1):104-13. PubMed ID: 15213851
[TBL] [Abstract][Full Text] [Related]
31. Aminophospholipid translocase and phospholipid scramblase activities in sickle erythrocyte subpopulations.
Barber LA; Palascak MB; Joiner CH; Franco RS
Br J Haematol; 2009 Aug; 146(4):447-55. PubMed ID: 19549270
[TBL] [Abstract][Full Text] [Related]
32. Correlation between calpain-mediated cytoskeletal degradation and expression of platelet procoagulant activity. A role for the platelet membrane-skeleton in the regulation of membrane lipid asymmetry?
Verhallen PF; Bevers EM; Comfurius P; Zwaal RF
Biochim Biophys Acta; 1987 Sep; 903(1):206-17. PubMed ID: 2820487
[TBL] [Abstract][Full Text] [Related]
33. Calpain cleaves phospholipid flippase ATP8A1 during apoptosis in platelets.
Jing W; Yabas M; Bröer A; Coupland L; Gardiner EE; Enders A; Bröer S
Blood Adv; 2019 Feb; 3(3):219-229. PubMed ID: 30674456
[TBL] [Abstract][Full Text] [Related]
34. L-carnitine inhibits a subset of platelet activation responses in chronic uraemia.
Bonomini M; Sirolli V; Dottori S; Amoroso L; Di Liberato L; Arduini A
Nephrol Dial Transplant; 2007 Sep; 22(9):2623-9. PubMed ID: 17478491
[TBL] [Abstract][Full Text] [Related]
35. Contribution of platelet microparticle formation and granule secretion to the transmembrane migration of phosphatidylserine.
Chang CP; Zhao J; Wiedmer T; Sims PJ
J Biol Chem; 1993 Apr; 268(10):7171-8. PubMed ID: 8463253
[TBL] [Abstract][Full Text] [Related]
36. Collagen but not fibrinogen surfaces induce bleb formation, exposure of phosphatidylserine, and procoagulant activity of adherent platelets: evidence for regulation by protein tyrosine kinase-dependent Ca2+ responses.
Heemskerk JW; Vuist WM; Feijge MA; Reutelingsperger CP; Lindhout T
Blood; 1997 Oct; 90(7):2615-25. PubMed ID: 9326228
[TBL] [Abstract][Full Text] [Related]
37. Arsenite-enhanced procoagulant activity through phosphatidylserine exposure in platelets.
Bae ON; Lim KM; Noh JY; Chung SM; Kim H; Lee CR; Park JD; Chung JH
Chem Res Toxicol; 2007 Dec; 20(12):1760-8. PubMed ID: 17915961
[TBL] [Abstract][Full Text] [Related]
38. Exposure of endogenous phosphatidylserine at the outer surface of stimulated platelets is reversed by restoration of aminophospholipid translocase activity.
Bevers EM; Tilly RH; Senden JM; Comfurius P; Zwaal RF
Biochemistry; 1989 Mar; 28(6):2382-7. PubMed ID: 2730870
[TBL] [Abstract][Full Text] [Related]
39. Annexin V as a probe of aminophospholipid exposure and platelet membrane vesiculation: a flow cytometry study showing a role for free sulfhydryl groups.
Dachary-Prigent J; Freyssinet JM; Pasquet JM; Carron JC; Nurden AT
Blood; 1993 May; 81(10):2554-65. PubMed ID: 8490169
[TBL] [Abstract][Full Text] [Related]
40. Platelet microparticle membranes have 50- to 100-fold higher specific procoagulant activity than activated platelets.
Sinauridze EI; Kireev DA; Popenko NY; Pichugin AV; Panteleev MA; Krymskaya OV; Ataullakhanov FI
Thromb Haemost; 2007 Mar; 97(3):425-34. PubMed ID: 17334510
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
